English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [455]
News [481]
Articles [75]
Editorials [1]
Conferences [102]
elearning [21]
ESMO 2024: Coaching programme for increased exercise in breast cancer patients
ESMO 2024: Coaching programme for increased exercise in breast cancer patients
ESMO 2024: Combination therapy reduced agitated delirium in patients with advanced cancers
ESMO 2024: Combination therapy reduced agitated delirium in patients with advanced cancers
New AI tool predicts risk for chronic pain in cancer patients
New AI tool predicts risk for chronic pain in cancer patients
Women with high-risk HPV and metabolic syndrome have almost three times risk for mortality, researchers find
Women with high-risk HPV and metabolic syndrome have almost three times risk for mortality, researchers find
Radioguided surgery accurately detects and removes metastatic lymph nodes in newly diagnosed prostate cancer patients
Radioguided surgery accurately detects and removes metastatic lymph nodes in newly diagnosed prostate cancer...
Consistent evidence links ultra-processed food to over 30 damaging health outcomes
Consistent evidence links ultra-processed food to over 30 damaging health outcomes
Sharing good practice ‘critical’ to improving UK lung cancer survival say experts
Sharing good practice ‘critical’ to improving UK lung cancer survival say experts
Study suggests improvements needed for patient-reported outcome data in genitourinary cancer clinical studies
Study suggests improvements needed for patient-reported outcome data in genitourinary cancer clinical studies
FDA approves pembrolizumab with chemotherapy for biliary tract cancer
FDA approves pembrolizumab with chemotherapy for biliary tract cancer
FDA approves ivosidenib for myelodysplastic syndromes
FDA approves ivosidenib for myelodysplastic syndromes
<12345...49>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top